Verisante Technology, Inc.

A better way to diagnose skin cancer to save lives and reduce health care costs

Led strategic earned media relations to raise awareness of the made-in-Vancouver Verisante Aura, an innovative, non-invasive skin cancer detection technology, among the medical community, business media, and patients. Verisante Aura was developed in partnership by the BC Cancer Agency, Vancouver General Hospital, and the University of British Columbia.  


Verisante Aura was co-invented by dermatologists who recognized that long wait times and limited tools to diagnose skin cancer were not serving patients well. The device shines laser light on a lesion, and in under a second, tells the dermatologist whether a biopsy is needed — accelerating the scanning and diagnostic process and improving patient outcomes.

A highly successful multi-year earned media campaign helped position the CEO of Verisante Technology as a strategic lead and the device’s co-inventors as experts in dermatology and cancer research.


Results

  • Secured 130 pieces of coverage and more than 60 million impressions in influential Canadian and international mainstream, business, and consumer media, including CNN, MIT Technology Review, The Globe and Mail, National Post, Maclean’s, Reader’s Digest, Chatelaine, and Canadian Business.

Previous
Previous

BC Centre for Excellence in HIV/AIDS

Next
Next

Metro Vancouver